Landmark Capital reserves a share of its budget dedicated to alternative investments also to venture capital and innovative start-ups, with a particular focus on health care and life science.

The company selects the investments in this sector through a partnership with the business angels network Italian Angels for Growth (IAG) and the biotech accelerator corporation BiovelocITA'.